|
Jun Lu, M.D., FAADAssociate Professor of DermatologyDirector, Clinical Research Unit Site Director, Residency program
|
|
||||||||||
- Education & Training
- Clinical Interests
- Teaching
- Committees & Organizations
- Research
- Research Opportunities
- Publications
- Presentations
Education
Post-Graduate Training
Awards
| Degree | Institution | Major |
|---|---|---|
| M.D. | China Medical University | Medicine |
| M.D., Ph.D. | China Medical University | M.D./Ph.D. Program |
Post-Graduate Training
| Training | Institution | Specialty |
|---|---|---|
| Research Fellow | Department of Immunology, Mayo Clinic | Research Fellow |
| Senior Postdoctoral Research Fellow | Department of Dermatology, Mayo Clinic | Senior Postdoctoral Research Fellow |
| Internship | Department of Medicine, Mayo Clinic | Internal Medicine |
| Residency | Department of Dermatology, Mayo Clinic | Dermatology |
Awards
| Name of Award/Honor | Awarding Organization |
|---|---|
| American Academy of Dermatology Presidential Citation Award | American Academy of Dermatology |
| Patient Care Hero by American Academy of Dermatology | American Academy of Dermatology |
| Cutting-Edge Research Award | American Society of Dermatology Surgery |
| Fraternal Order of Eagles Award for Cancer Research | Mayo Clinic |
| Young Investigator Award | American Association of Cancer Research |
| Top Ten University Student | Liaoning Province |
General dermatology; connective tissue disease including cutaneous lupus and dermatomyositis; inflammatory skin disorders including psoriasis, eczema, and hidradenitis suppurativa; clinical trials on new dermatological therapies
Medical school core corriculum, medical school coaching program, Dermatology residency program site director, clinical trial fellowship program director
| Name & Description | Category | Role | Type | Scope | Start Year | End Year |
|---|---|---|---|---|---|---|
| International Women's Society of Dermatology | Professional/Scientific Journal | reviewer | External | International | 2014 | |
| Journal of American Academy of Dermatology | Professional/Scientific Journal | reviewer | External | International | 2014 | |
| American Association of Dermatology | Professional/Scientific Organization | Member | External | National | ||
| American Society of Investigative Dermatology | Professional/Scientific Organization | Member | External | National | ||
| International Society for Dermatology | Professional/Scientific Organization | Member | External | International |
Connective tissue disease and inflammatory diseases, cutaneous lupus and dermatomyositis registry, psoriais registry, clinical trials for psoriasis and eczema
Clinical trial research gap year for medica student
Journal Articles
-
Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review.
Journal of the American Academy of Dermatology 2023 Apr;
-
Impact of dermoscopy-aided pediatric teledermatology program on the accessibility and efficiency of dermatology care at community health centers.
Journal of telemedicine and telecare 2021 Dec;1357633X211068275
-
NUTRITION AND BULLOUS DISEASES.
Clinics in dermatology 2021 Nov;
-
The "deck-chair sign" as an early diagnostic clue in dermatomyositis.
International journal of dermatology 2021 Mar;
-
Pacinian Corpuscle Hyperplasia: A Review of the Literature
Int J of Women’s Dermatol 2020 Oct;
-
Nutrition and Autoimmune Bullous Disease.
Clin Dermatol. 2020 Jul;
-
Nutrition and Connective Tissue Diseases
Clin Dermatol. 2020 Jul;
-
Dermatomyositis Part 2: Diagnosis and Treatment.
Journal of the American Academy of Dermatology 2020 Feb;
-
Dermatomyositis Part I: Clinical Features and Pathogenesis.
Journal of the American Academy of Dermatology 2020 Feb;
-
Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients.
Journal of the American Academy of Dermatology 2020 Jan;
-
Impact of a combined dermatology-rheumatology clinic on management of autoimmune connective tissue disorders.
Clinical and experimental dermatology 2018 Sep;
-
Histological features and outcome of inverted type-A melanocytic nevi.
Journal of cutaneous pathology 2018 Apr;45(4):254-262
-
Impact of dermatology eConsults on access to care and skin cancer screening in underserved populations: A model for teledermatology services in community health centers.
Journal of the American Academy of Dermatology 2017 Oct;78293-302
-
Management of severe acne during pregnancy: A case report and review of the literature.
International journal of women's dermatology 2017 Sep;3(3):145-150
-
Successful treatment of hydroxyurea-associated panniculitis and vasculitis with low-dose methotrexate.
JAAD case reports 2017 Sep;3(5):422-424
-
Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis.
PloS one 2011 Jan;6(4):e18266
-
Combination cytokine therapy inhibits tumor growth by generation of tumor-specific T-cell responses in a murine melanoma model.
Cytokine 2010 Mar;49(3):287-93
-
Identify Effect of Amphiregulin on Keratinocytes and T cells in Psoriasis.
Psoriasis Forum 2010 Jan;
-
Global survey of human T leukemic cells by integrating proteomics and transcriptomics profiling.
Mol & Cell Proteomics 2007 Jan;6(8):1343-1353
-
Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses.
Journal of immunology (Baltimore, Md. : 1950) 2004 Apr;172(7):4575-82
-
Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2.
Tissue antigens 2003 Aug;62(2):139-48
-
Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Dec;8(12):3877-84
-
Recognition of prostate tumor cells by cytotoxic T lymphocytes specific for prostate-specific membrane antigen.
Cancer research 2002 Oct;62(20):5807-12
-
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Nature medicine 2002 Aug;8(8):793-800
-
Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Jul;8(7):2336-44
-
Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Cancer research 2002 Mar;62(6):1884-9
-
Direct constimulation of tumor-reactive CTL by helper T cells potentiates their proliferation, survival and effector function
Clinical Cancer Research 2002 Jan;8(3):922-31
-
Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.
Cancer research 2001 Oct;61(20):7577-84
-
TAP-independent presentation of CTL epitopes by Trojan antigens.
Journal of immunology (Baltimore, Md. : 1950) 2001 Jun;166(12):7063-71
-
Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
Cancer research 2000 Sep;60(18):5223-7
-
MHC-binding peptides as immunotherapeutics for cancer.
Immunological investigations 2000 May;29(2):105-10
-
Ocular and eyelid involvement in collagen vascular diseases. Part I. Sjogren’s Syndrome and Systemic Lupus Erythematosus. Clinics in Dermatology.
Clinics in Dermatology.
-
S Ocular and eyelid involvement in collagen vascular diseases. Ocular and eyelid involvement in collagen vascular diseases. Part II. Dermatomyositis, Scleroderma and Sarcoidosis. Clinics In Dermatology.
Clinics In Dermatology
Book Chapters
-
1. Pemphigus Vulgaris
2. Bullous pemphigoid
3. Drug induced Pemphigus Vulgaris and Bullous pemphigoid
4. Discoid lupus erythematous and Acute cutaneous lupus erythematosus
5. Hidradenitis Supprutiva
6. Pityriasis Rosea
7. Polymorphous Light eruption
8. Leukocytoclastic vaculitis
Dermatology for the Primary Care Provider
Case Reports
-
Atypical Wells syndrome successfully treated with dupilumab.
Skin health and disease 2023 Jun;3(3):e206
Letters
-
Comment on: "The growth of teledermatology: Expanding to reach the underserved".
Journal of the American Academy of Dermatology 2021 Apr;
-
Letter in Reply: Toward a COVID-19 Vaccine Strategy for Pemphigus Patients on Rituximab.
Journal of the American Academy of Dermatology 2020 Oct;
-
Response to: "Applying to dermatology residency during the COVID-19 pandemic".
Journal of the American Academy of Dermatology 2020 Sep;
-
Reply to: Saardi et al.
Journal of the American Academy of Dermatology 2020 Mar;
Reviews
-
Patient Satisfaction in Teledermatology: an Updated Review.
Current dermatology reports 2023 Jan;12(1):23-26
-
Adult and juvenile dermatomyositis treatment.
Journal of cosmetic dermatology 2022 Sep;
-
Emerging Therapeutics in the Management of Connective Tissue Disease. Part I. Lupus Erythematosus and Sjögren's Syndrome.
Journal of the American Academy of Dermatology 2022 Feb;
-
Emerging Therapeutics in the Management of Connective Tissue Disease. Part II. Dermatomyositis and Scleroderma.
Journal of the American Academy of Dermatology 2022 Feb;
-
Pacinian corpuscle hyperplasia: A review of the literature.
International journal of women's dermatology 2021 Jun;7(3):335-341
-
Cutaneous Features and Diagnosis of Primary Sjogren's Syndrome: An Update and Review.
Journal of the American Academy of Dermatology 2018 May;79736-745
-
Teledermatology: An updated overview of clinical applications and reimbursement policies.
International journal of women's dermatology 2017 Sep;3(3):176-179
| Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
|---|---|---|---|---|
| Emerging therapies for dermatomyositis | Plenary Lecture | The 4th International Dermatology Drug Development Summit | 2020 | Boston (virtual) |
| Dupilumab for the treatment of dyshidrotic eczema for 15 consecutive patients | Lecture | AAD annual meeting | 2020 | |
| What's new in bullous pemphigoid Current Clinical Medicine CME course 2016-2017 UConn School of Medicine | Lecture | 2016 | Uconn Medical School | |
| What’s new in bullous pemphigoid? | Lecture | Grand Round Department of Dermatology University of Connecticut | 2013 | University of Connecticut Farmington CT |
| Diagnosis and treatment of Autoimmune bullous diseases | Lecture | Department of Medicine Grand Round Hartford Hospital | 2013 | Hartford Hospital Hartford CT |
| Amphiregulin Induces T cell Activation Through Cytokine Circuits in Psoriasis-like Transgenic Mice Model | Lecture | Annual meeting of American Society of Investigative Dermatology | 2009 | |
| Amphiregulin Regulates Keratinocyte and T cell Interactions: A Key Mediator in Psoriasis | Poster | International Society of Investigative Dermatology | 2008 | |
| Overlap Syndrome of Scleroderma (systemic sclerosis) and Scleredema. | Lecture | Minnesota Derm | 2007 | |
| Gene Expression Analysis in Human Amphiregulin Transgenic Mice Revealed Psoriasis-like Profiling and Novel Immune Regulatory Pathways | Lecture | Annual meeting of American Society of Investigative Dermatology | 2007 | |
| Psoriasis-like Skin Pathology in Human Amphiregulin Transgenic Mice is Correlated with CD44hi CD62Lloeffector Memory T Cell Phenotype and TCR Repertoire Restriction | Lecture | Annual meeting of American Society of Investigative Dermatology | 2006 | |
| Pityriasis Rubra Pilaris | Talk | Minnesota Derm | 2006 | |
| Identification Peptide Epitopes from Prostate Specific Membrane Antigen That Induce Tumor-reactive Cytotoxic T Lymphocytes | Talk | Annual meeting of American Association of Cancer Research | 2003 | |
| Helper T Cells Potentiate the Effector Function and Growth of Anti-Tumor Cytotoxic T Lymphocytes | Lecture | Annual meeting of American Association of Immunology | 2002 | |
| IL-15 Promotes Antigen-Independent In Vitro Expansion and Long-Term Survival of Effector CTL | Poster | Annual meeting of American Association of Cancer Research | 2001 |